Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV.
Clinical trial NCT06332339 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06332339
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2026-11-11
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.